Study suggests that minds may wander less as we age

We’re all guilty of letting our minds wander when we’re supposed to be doing something else. A little distraction is likely inevitable. But a study led by Matt Welhaf, a postdoctoral researcher in psychological and brain sciences in Arts & Sciences at Washington University in St. Louis, reveals a surprising trend: Our minds wander less as we age and, when older adults do let their minds drift, they’re more likely to be distracted by pleasant thoughts rather than worries.

Use of GLP-1 receptor agonists to treat substance and alcohol use disorders is promising, but premature, say researchers

Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) originally formulated to treat diabetes, has gained traction as the latest and greatest weight loss drug. Among the hype, anecdotal observations from patients and providers alike have suggested the drug may also play a role in treating alcohol use disorder and other substance use disorders.

Be patient, Vedanta tells contractors

…who have complained that the continued delay in settling the US$250 million owed to contractors, suppliers has created anxiety, uncertainty in the sector  

By NATION REPORTER

THE Association of Mine Suppliers and Contractors has bemoaned the delays by Vedanta Resources to pay the US$250 million it owes to contractors.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Medicare is overpaying for generic drugs: Study

Medicare is the single largest provider of health insurance in the United States, serving 63.8 million senior citizens as of 2022. Three-quarters of these recipients are enrolled in optional Medicare Part D plans, which provide outpatient prescription drug coverage to seniors through private insurance companies. In 2022, Medicare paid more than $160 Billion for prescription drugs, making it the single largest payer of pharmaceuticals in the US.